ACM
AIMT

Atika Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Atika Capital Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-98,000
Closed -$3.12M – 98
2018
Q1 		$3.12M Buy
98,000
+13,000
+15% +$414K 1.07% 34
2017
Q4 		$3.22M Buy
+85,000
New +$3.22M 1.24% 34